Article
Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae.
Analytical chemistry - 16 Sept 2025
Zhao Ziyuan, Li Yamei, Xiu Leshan, Wang Feng, Peng Junping
Abstract excerpt
Gonorrhea has become an escalating public health issue due to the rapid emergence of antimicrobial resistance (AMR). Developing efficient and accurate detection of resistant strains is urgently needed for their management and treatment. We have developed the Multiplex Integrated RPA-CRISPR/Cas12a detection Assay (MIRCA) for simultaneous detection of Neisseria gonorrheae (Ng) and mutations with decreased...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
